Related Experiment Video

Updated: Aug 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis

X Hu1, K S Zuckerman

  • 1Interdisciplinary Oncology Program, University of South Florida, and H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA. hu@moffitt.edu

Journal of Hematotherapy & Stem Cell Research
|March 29, 2001
PubMed

Insights

Transforming growth factor-beta (TGF-beta) inhibits cell growth by down-regulating cyclin-dependent kinases and affecting retinoblastoma protein (pRb) phosphorylation. This leads to cell cycle arrest at G1 by altering E2F-4 complex formation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGF-beta) is a key regulator of cell growth and differentiation.
  • TGF-beta exerts its effects through specific cell surface receptors (TGFbetaRI and TGFbetaRII).
  • Dysregulation of TGF-beta signaling is implicated in various cancers, including myeloid leukemia.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which TGF-beta(1) induces cell cycle arrest in human myeloid leukemia cells.
  • To investigate the role of Smad proteins, cyclin-dependent kinases (cdks), and retinoblastoma protein (pRb) in TGF-beta(1)-mediated G1 arrest.
  • To analyze the interaction of pRb family members with E2F transcription factors upon TGF-beta(1) treatment.

Main Methods:

  • Treatment of human myeloid leukemia cells with TGF-beta(1).
  • Analysis of cell cycle progression and arrest.
  • Western blotting to assess protein levels and phosphorylation status of key cell cycle regulators (cdks, cyclins, pRb, p130, p107, E2F family members).
  • Immunoprecipitation to study protein-protein interactions, specifically pRb family members with E2F-4.

Main Results:

  • TGF-beta(1) treatment resulted in G1 cell cycle arrest.
  • TGF-beta(1) down-regulated the activity and protein levels of G1 and G2 cyclins and cdks.
  • TGF-beta(1) inhibited pRb phosphorylation, leading to increased association of underphosphorylated pRb with E2F-4.
  • TGF-beta(1) promoted p130/E2F-4 complex formation and reduced p107/E2F-4 complex formation, indicating a switch in E2F-4 binding partners.
  • The cdk inhibitor p27 was identified as a regulator in this process.

Conclusions:

  • TGF-beta(1) effectively inhibits proliferation of both normal hematopoietic stem cells and myeloid leukemia cell lines.
  • The G1 arrest induced by TGF-beta(1) is mediated by down-regulation of cdks/cyclins and altered pRb/E2F complex formation.
  • TGF-beta(1) signaling promotes cell cycle exit by facilitating the dissociation of E2F-4 from p107 and its subsequent association with pRb and p130.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...